comparemela.com

Latest Breaking News On - Enhancement plan - Page 8 : comparemela.com

Alkermes To Spin-Off Mural Oncology In 2H23

ALKS, $31.48, Market Capitalization: $5.2 billion), a fully-integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience .

United statesCarolinej loewArthur coxExchange commissionMorgan stanleyCompany descriptionGoodwin procterMarket capitalizationUnited states securitiesMural oncologyAlkerme boardGeneral meetingRichard popsChief executive officerBofa securitiesEnhancement plan

Alkermes Publishes Investor Presentation Detailing Company s Transformation and Value Creation

/PRNewswire/ Alkermes plc (Nasdaq: ALKS) (the Company) today announced that it has filed an investor presentation with the U.S. Securities and Exchange.

United statesAlexander dennerKatie joyceSandy coombsChris kittredge zachary tramontiShanem cookeCatot laurencinRichardb gaynorChristopheri wrightEmily peterson alvaBrianp mckeonInnisfree ma incorporatedCorporate governance committeeCompany boardCompany annual report on formExchange commission

Alkermes plc: Alkermes Publishes Investor Presentation Detailing Company s Transformation and Value Creation

Strategic, Operational and Governance Enhancements Have Driven Strong Stock Price Performance and TSR Outperformance in Comparison to Peers Reiterates Board's Belief that Sarissa Nominees

United statesMecklenburg vorpommernCatot laurencinEmily peterson alvaChris kittredge zachary tramontiKatie joyceChristopheri wrightSandy coombsAlexander dennerRichardb gaynorShanem cookeBrianp mckeonStefan klotterEmergent biosolutions incJazz pharmaceuticalsAcadia pharmaceuticals inc

Alkermes Files Definitive Proxy Statement and Issues Letter to Shareholders Detailing Business Execution That Has Driven Strong Performance and Delivered Shareholder Value

/PRNewswire/ Alkermes plc (Nasdaq: ALKS) (the Company) today filed its definitive proxy statement with the U.S. Securities and Exchange Commission (SEC) and.

United statesRichardb gaynorDavid amsellemEmily peterson alvaDavida daglioPiper sandlerSandy coombsChristopheri wrightMarc goodmanAkash tewariChris kittredge zachary tramontiNancyj wysenskiKatie joyceCatot laurencinShanem cookeJessica fye

Alkermes plc: Alkermes Files Definitive Proxy Statement and Issues Letter to Shareholders Detailing Business Execution That Has Driven Strong Performance and Delivered Shareholder Value

Company Has Outperformed Peers and Relevant Indices Since Unveiling its December 2020 Value Enhancement Plan 70% of Board's Independent Directors Have Been Appointed Over the Last Four

United statesDavid amsellemRichardb gaynorGewinn nurSandy coombsChristopheri wrightMarc goodmanAkash tewariPiper sandlerDavida daglioEmily peterson alvaKatie joyceNancyj wysenskiChris kittredge zachary tramontiShanem cookeJessica fye

vimarsana © 2020. All Rights Reserved.